Home › Funds › Jupiter Topco LLC › BBIO

Jupiter Topco LLC position in BBIO

BRIDGEBIO PHARMA INC · Health Care

Jupiter Topco LLC reported holding 14,110,278 shares of BBIO (BRIDGEBIO PHARMA INC) in its Q2 2026 13F filing — a position valued at US$1.05B, representing 0.44% of its reported portfolio and ranking #41 among its reported holdings. Jupiter Topco LLC first reported this position in Q2 2026.

Latest position (Q2 2026)14.11M sh
Reported value held$1.05B
Portfolio Weight0.44%
First reportedQ2 2026
Last changeNew
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How Jupiter Topco LLC's BBIO position evolved

Jupiter Topco LLC first disclosed a stake in BBIO in Q2 2026 at 14,110,278 shares (US$1.05B).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 14.11M $1.05B New

About BBIO and 13F data

BBIO (BRIDGEBIO PHARMA INC) is a Health Care company. 47 other funds we track also report a position in BBIO — the largest reported positions include Janus Henderson Group (US$978.6M), Farallon Capital Management (US$800.1M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$800.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBIO

All BBIO fund holders →

FAQ

How long has Jupiter Topco LLC held BBIO?

Jupiter Topco LLC has disclosed BBIO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Jupiter Topco LLC's current position in BBIO?

As of Q2 2026, Jupiter Topco LLC holds 14.11M shares of BBIO (BRIDGEBIO PHARMA INC), valued at $1.05B, representing 0.44% of its reported portfolio and ranking #41.

Has Jupiter Topco LLC been buying or selling BBIO?

In the latest 13F filing (Q2 2026), Jupiter Topco LLC newly opened its position in BBIO.

Which other funds hold BBIO?

Other major institutional holders of BBIO include Janus Henderson Group, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.